| 1. | Tindal EW, Armstead BE, Monaghan SF,  et al. Emerging therapeutic targets for sepsis. Expert Opin Ther Targets, 2021, 25(3): 175-189. | 
				                                                        
				                                                            
				                                                                | 2. | 徐靜媛, 邱海波. 膿毒癥治療的現狀與展望. 國際流行病學傳染病學雜志, 2021, 48(4): 259-262. | 
				                                                        
				                                                            
				                                                                | 3. | 李曉丹, 馬青變. 2019~2020年膿毒癥研究領域熱點回顧. 中國急救醫學, 2021, 41(1): 21-27. | 
				                                                        
				                                                            
				                                                                | 4. | 胡暢, 胡波, 李志峰, 等. 四種評分系統對膿毒癥患者ICU死亡風險的預測價值比較. 南方醫科大學學報, 2020, 40(4): 513-518. | 
				                                                        
				                                                            
				                                                                | 5. | Lee SG, Song J, Park DW,  et al. Prognostic value of lactate levels and lactate clearance in sepsis and septic shock with initial hyperlactatemia: a retrospective cohort study according to the Sepsis-3 definitions. Medicine (Baltimore), 2021, 100(7): e24835. | 
				                                                        
				                                                            
				                                                                | 6. | Blutinger AL, Zollo AM, Weltman J,  et al. Prospective evaluation of plasma lactate parameters for prognosticating dogs with shock. J Vet Emerg Crit Care (San Antonio), 2021, 31(3): 351-359. | 
				                                                        
				                                                            
				                                                                | 7. | Moon JI, Shin J, Hwang JH,  et al. Impact of left ventricular function on tissue perfusion and renal outcomes in patients with sepsis. Clin Nephrol, 2021, 95(5): 247-255. | 
				                                                        
				                                                            
				                                                                | 8. | 肖巖, 楊愛國. 重癥膿毒血癥患兒血乳酸水平變化及其與凝血功能異常的關系. 血栓與止血學, 2022, 28(2): 248-249. | 
				                                                        
				                                                            
				                                                                | 9. | 中國醫師協會急診醫師分會, 中國研究型醫院學會休克與膿毒癥專業委員會. 中國膿毒癥/膿毒性休克急診治療指南(2018). 感染、炎癥、修復, 2019, 20(1): 3-22. | 
				                                                        
				                                                            
				                                                                | 10. | 韓天勇, 程濤, 何亞榮, 等. 急性生理學評分對老年膿毒癥患者院內死亡風險的預測價值. 醫學研究雜志, 2022, 51(2): 33-37. | 
				                                                        
				                                                            
				                                                                | 11. | Deng C, Zhao L, Yang Z,  et al. Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury. Acta Pharmacol Sin, 2022, 43(3): 520-528. | 
				                                                        
				                                                            
				                                                                | 12. | Almalki WH. The sepsis induced defective aggravation of immune cells: a translational science underling chemico-biological interactions from altered bioenergetics and/or cellular metabolism to organ dysfunction. Mol Cell Biochem, 2021, 476(6): 2337-2344. | 
				                                                        
				                                                            
				                                                                | 13. | 林孟相, 魏宏建, 付春來, 等. 膿毒癥患者血小板膜糖蛋白CD62p和CD63的表達及其臨床意義. 中國呼吸與危重監護雜志, 2007, 6(3): 205-207,229. | 
				                                                        
				                                                            
				                                                                | 14. | Ravikumar N, Sayed MA, Poonsuph CJ,  et al. Septic cardiomyopathy: from basics to management choices. Curr Probl Cardiol, 2021, 46(4): 100767. | 
				                                                        
				                                                            
				                                                                | 15. | Kudo D, Goto T, Uchimido R,  et al. Coagulation phenotypes in sepsis and effects of recombinant human thrombomodulin: an analysis of three multicentre observational studies. Crit Care, 2021, 25(1): 114. | 
				                                                        
				                                                            
				                                                                | 16. | 伊孫邦, 胡雨峰, 林素涵, 等. 不同時間段血乳酸水平對膿毒癥院內死亡的預測價值比較: 基于重癥監護醫學信息數據庫. 中華危重癥醫學雜志(電子版), 2020, 13(1): 39-43. | 
				                                                        
				                                                            
				                                                                | 17. | 沈瑞環, 王旭, 魯中原. 疾病嚴重程度評分在心臟術后膿毒癥診斷及遠期預后預測中的價值. 中國胸心血管外科臨床雜志, 2022, 29(2): 219-227. | 
				                                                        
				                                                            
				                                                                | 18. | Vincent JL, Bakker J. Blood lactate levels in sepsis: in 8 questions. Curr Opin Crit Care, 2021, 27(3): 298-302. |